| Profile | GDS1873 / 212718_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 2221.41 | 95 |
| GSM40788 | control - Rep 2 | 1959.32 | 95 |
| GSM40789 | control - Rep 3 | 2124.35 | 95 |
| GSM40775 | androgen treated - Rep 1 | 2044.47 | 95 |
| GSM40776 | androgen treated - Rep 2 | 2292.02 | 96 |
| GSM40777 | androgen treated - Rep 3 | 2046.76 | 95 |
| GSM40790 | estrogen treated - Rep 1 | 2212.8 | 95 |
| GSM40791 | estrogen treated - Rep 2 | 2406.52 | 96 |
| GSM40792 | estrogen treated - Rep 3 | 2381.02 | 96 |
| GSM40784 | A + tamoxifen - Rep 1 | 2207.69 | 95 |
| GSM40785 | A + tamoxifen - Rep 2 | 2313.82 | 96 |
| GSM40786 | A + tamoxifen - Rep 3 | 2348.93 | 96 |
| GSM40778 | A + anastrozole - Rep 1 | 1919.71 | 95 |
| GSM40779 | A + anastrozole - Rep 2 | 2313.37 | 95 |
| GSM40780 | A + anastrozole - Rep 3 | 2039.4 | 95 |
| GSM40781 | A + letrozole - Rep 1 | 1599.09 | 94 |
| GSM40782 | A + letrozole - Rep 2 | 2074.95 | 95 |
| GSM40783 | A + letrozole - Rep 3 | 2338.6 | 96 |